Pfizer sends shockwave through vaccine industry with Omicron variant announcement

The Omicron variant was isolated less than a month ago in Botswana, but Pfizer claims its existing booster provides the missing protection that the “vaccine” lacks. This is a particularly questionable claim that warrants further investigation.

“Preliminary laboratory studies suggest that two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses may neutralize it,” the companies said. said in a New information posted on Wednesday,” CNN reported dispassionately.

“Samples from people who had received two doses of the Covid-19 vaccine showed a more than 25-fold reduction in neutralization against the Omicron variant compared with the previous virus, suggesting that two doses of BNT162b2 may not be sufficient for CNN. quoted the company said.

This is a complete admission that previous “vaccines” did little to prevent the spread of the Omicron variant. Here’s what Pfizer claims about showing “preliminary” data, according to its release.

  • Preliminary laboratory studies demonstrate that three doses of Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (series B.1.1.529) while two doses show a significantly reduced neutralizing titer
  • The data indicated that the third dose of BNT162b2 increased the neutralizing antibody titre 25-fold compared with two doses for the Omicron variant; titers after booster dose comparable to those observed after two doses against wild-type virus are associated with a high degree of protection
  • Since 80% of the epitopes in the mutant protein recognized by CD8+ T cells are unaffected by mutations in the Omicron variant, two doses may still confer protection against severe disease.
  • The companies continue to push for the development of a specific variant vaccine for Omicron and expect it to be available in March in case it needs to be adjusted to further increase the level and duration of protection. protection – no changes for the four companies. billion dose capacity for 2022

Albert Bourla, President and CEO, Pfizer said: “Although two doses of the vaccine can still protect against serious diseases caused by the Omicron strain, it is clear from these preliminary data. that protection improves with the third dose of our vaccine.” . “Ensuring as many people as possible are fully immunized with the first two doses and that the booster is still the best course of action to stop the spread of COVID-19. ”

This is an absolute lie. It’s not surprising that a CEO of Big Pharma lied about his product. But the US government and the business press turned a blind eye to an issue of great public importance, and Americans were outraged.

As stated in court documents In a lawsuit against the FDA this week, the “vaccine” completely failed to stop the spread of Covid-19. Therefore, there is no public health reason to authorize or require them to travel.

“The pandemic is continuing to spiral. Although more than 83% of adults have been vaccinated against COVID-19, cases are on the rise in the most vaccinated states, variants that evade vaccine immunity are on the rise, the CDC has acknowledged. Receiving a COVID-19 vaccine does not prevent transmission, the number of Breakthrough Cases is growing exponentially, and boosters are now needed by everyone and will likely continue to be required. every six months, if not more often, among many other problems with the vaccine program,” argued the Public Health attorney and Medical Expert for Transparency.

As previously reported, Big Pharma companies announced that they are “confident” that they can quickly develop a vaccine for the Omicron variant. Pfizer-BioNTech went further with the idea of ​​a “reboot” vaccine.

But as medical researchers have discovered, Omicron is a “generally mild” variant of the original strain.

“Covid symptoms associated with the new omicron variant have been described as ‘extremely mild’ by the South African doctor who first raised the alarm about the new strain of bacteria,” CNBC reported.

However, Pfizer is touting the need for a “booster” shot of a virus being compared to a Common Cold coronavirus. This is the Brave New World we are in.

It is particularly suspected that Pfizer “booster” somehow neutralized a variant that had just arisen on an African continent that had prevented the spread of the Covid-19 virus. (This is believed in part to be due to the widespread use of antimalarial drugs with antiviral properties.)

But given the “procrastination” among the first millions of people burned by pharmaceutical companies lying about purported “vaccines,” Pfizer clearly had an all-too-perfect solution.

A month after the Omicron variant was “discovered”, Pfizer says its booster fixes it completely Vaccine‘ineffective.

It’s convenient, isn’t it? Pfizer sends shockwave through vaccine industry with Omicron variant announcement

Huynh Nguyen

Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button